Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epithelioid sarcoma
epithelioid sarcoma
Epizyme drug granted approval by FDA for rare cancer
BioPharma Dive
Thu, 01/23/20 - 11:52 pm
Epizyme
FDA
Tazverik
Eisai
epithelioid sarcoma
FDA’s in-house review offers bleak assessment of Epizyme’s tazemetostat — but win or lose this cancer drug may still have a future
Endpoints
Tue, 12/17/19 - 10:27 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
Epizyme announces FDA filing acceptance of new drug application and priority review for tazemetostat to treat epithelioid sarcoma
Pharmaceutical Business Review
Fri, 07/26/19 - 11:02 am
Epizyme
FDA
tazemetostat
epithelioid sarcoma
ASCO: With FDA review nearing, Epizyme shares updated sarcoma data
Fierce Biotech
Mon, 06/3/19 - 11:32 am
ASCO 2019
Epizyme
clinical trials
tazemetostat
epithelioid sarcoma
Epizyme moves forward with cancer drug, eyes 2020 launch
Biopharma Dive
Thu, 05/30/19 - 05:37 pm
Epizyme
FDA
tazemetostat
epithelioid sarcoma